Skip to main content
. 2024 Mar 19;25(6):3448. doi: 10.3390/ijms25063448

Table 2.

Comparison of AhR agonistic activity induced by Trp and its 15 metabolites.

Compound REC10 (a) Relative Potency (b)
TCDD 1.0 × 10−12 1
L-Tryptophan N.E. (c) <3.3 × 10−9
L-Kynurenine 7.0 × 10−7 1.4 × 10−6
Tryptamine 6.3 × 10−5 1.6 × 10−8
3-Methylindole 7.8 × 10−5 1.3 × 10−8
Xanthurenic acid 1.2 × 10−4 8.3 × 10−9
5-Hydroxyindole-3-acetic acid 1.5 × 10−4 6.7 × 10−9
Indole-3-carboxylic acid N.E. <3.3 × 10−9
Indole-3-carboxaldehyde N.E. <3.3 × 10−9
Indole-3-acetamide N.E. <3.3 × 10−9
3-Indoleacetic acid N.E. <3.3 × 10−9
3-Indolepropionic acid N.E. <3.3 × 10−9
Indole N.E. <3.3 × 10−9
Kynurenic acid N.E. <3.3 × 10−9
Anthranilic acid N.E. <3.3 × 10−9
Pyridine-2-carboxylic acid N.E. <3.3 × 10−9
2,3-Pyridinedicarboxylic acid N.E. <3.3 × 10−9

(a) 10% relative effective concentration (M): the concentration of the test compound showing 10% of the agonistic activity induced by 1 × 10−10 M TCDD. (b) Relative potency is expressed as a ratio of REC10 of TCDD to that of a test compound; i.e., the relative potency of TCDD is arbitrarily set at 1. (c) No effect (REC10 > 3 × 10−4 M).